Variant report
Variant | esv2761580 |
---|---|
Chromosome Location | chr10:23804215-23806382 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:23793550..23795585-chr10:23803256..23805113,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7913401 | chr10:23804215-23804216 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs532459013 | chr10:23804221-23804222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78810748 | chr10:23804230-23804231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571439050 | chr10:23804249-23804250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530854832 | chr10:23804270-23804271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11596212 | chr10:23804274-23804275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550878299 | chr10:23804308-23804309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141296328 | chr10:23804317-23804318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369497411 | chr10:23804338-23804339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375757905 | chr10:23804344-23804345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536249847 | chr10:23804350-23804351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11013547 | chr10:23804371-23804372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561864461 | chr10:23804389-23804390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1985697 | chr10:23804407-23804408 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs11594755 | chr10:23804434-23804435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544460781 | chr10:23804436-23804437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370718103 | chr10:23804441-23804442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185631305 | chr10:23804445-23804446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189274618 | chr10:23804446-23804447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs115191417 | chr10:23804484-23804485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544541016 | chr10:23804542-23804543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539211175 | chr10:23804579-23804580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554835881 | chr10:23804590-23804591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574541579 | chr10:23804616-23804617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540629673 | chr10:23804626-23804627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560250737 | chr10:23804636-23804637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs191453549 | chr10:23804666-23804667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533064766 | chr10:23804669-23804670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551461225 | chr10:23804674-23804675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183739675 | chr10:23804746-23804747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1856113 | chr10:23804769-23804770 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs12243222 | chr10:23804796-23804797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145077140 | chr10:23804849-23804850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138803190 | chr10:23804883-23804884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs529907081 | chr10:23804899-23804900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546592015 | chr10:23804946-23804947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs74686186 | chr10:23804948-23804949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs527317020 | chr10:23804953-23804954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73602575 | chr10:23804957-23804958 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs569151258 | chr10:23804964-23804965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7067635 | chr10:23805013-23805014 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs149357324 | chr10:23805021-23805022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188871178 | chr10:23805032-23805033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540539563 | chr10:23805061-23805062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568697169 | chr10:23805072-23805073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577152197 | chr10:23805086-23805087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546318274 | chr10:23805119-23805120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs143802494 | chr10:23805152-23805153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs576557599 | chr10:23805195-23805196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs369568292 | chr10:23805219-23805220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Esophageal cancer | 21851588 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Behavioral abnormalities | 21522184 | CNVD |
Dysmorphic features | 21522184 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:23803800-23805600 | Enhancers | Hela-S3 | cervix |
2 | chr10:23805600-23806800 | Enhancers | Liver | Liver |
3 | chr10:23805600-23806800 | Enhancers | HepG2 | liver |
4 | chr10:23806200-23807000 | Enhancers | Primary monocytes fromperipheralblood | blood |